Activity-Based Aptamers as Next-Generation Bioimaging Tools and Diagnostics

​


Invention Summary:

As more and diverse biomarkers are identified for critical pathophysiological processes, there is a growing need to develop easily applied, reliable, and adaptable diagnostic tools.

Rutgers researchers have developed a smart molecular toolbox that fulfill these criteria. This toolbox, termed the activity-based aptamer (ABA) system, enables a single nucleic acid scaffold to detect unique and structurally diverse disease-associated biomarkers, ranging from organic and inorganic small molecules to enzymes. Furthermore, surfaces that are grafted with these ABA systems have the potential to introduce multiplexed detection and reusability capabilities into diagnostics.  

Market Applications:

In vitro, in cellulo, and on-chip detection of biomarkers that are associated with human diseases and infectious organisms 

Advantages:

  • Highly configurable 

  • A single working platform to detect a wide range of biomarkers 

  • Bioorthogonal 

Intellectual Property & Development Status: Patent pending. Available for licensing and/or research collaboration. For any business development and other collaborative partnerships, contact:  marketingbd@research.rutgers.edu

Patent Information:
Licensing Manager:
Lisa Lyu
Assistant Director
Rutgers, The State University of New Jersey
848-932-4539
lisa.lyu@rutgers.edu
Business Development:
Eusebio Pires
Senior Manager, Technology Marketing & Business Development
Rutgers, The State University of New Jersey
ep620@research.rutgers.edu
Keywords:
Biosensor